Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing ...

West Pharmaceutical Services’ first quarter results drew a negative market response, despite the company surpassing Wall ...

Pharmaceutical partners are now repeatedly seeking to become integrated care providers, wanting to play a bigger supporting role and thus are investing in services alongside their product offering.

West Pharmaceutical Services beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $748.8 million, up 2.3% year on year. It was a softer quarter for the company, ...

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acqu ...

Pharma companies are expending considerable time, energy and money on developing services that are designed to support patients before, during and after treatment across therapeutic areas.

A high-level overview of West Pharmaceutical Services, Inc. (WST) stock. View (WST) real-time stock price, chart, news, analysis, analyst reviews and more.

West Pharmaceutical Services Inc. closed 38.11% below its 52-week high of $352.33, which the company reached on October 24th.

As a critical component of Piramal Pharma's integration, the site provides fill/finish services for all integrated programs, including ADCelerate projects. The expansion will add commercial-scale ...